The TAIL-PrEP Study

Inclusion criteria: * At least 18 years of age * Have discontinued cab-LA injections within the last three months * Not currently on cab-LA injections * HIV-negative (self-report) * Able to speak and read in English or Spanish, * Able to receive and send monthly packages * Have access to an internet-connected device capable of running the Zoom video conferencing platform * Have a private location at which to take Zoom calls The study period will end for patient participants once the monthly blood draw result indicates that cab-LA levels are not detectable (estimated average of 6 months across all patients) or after 6 months of the study, whichever comes first. If at 6 months of study participation, cab-LA levels are still detectable and participants adhered to at least 50% of study activities (self-collecting and mailing monthly blood samples, completing monthly surveys, attending monthly coaching sessions), participants will be invited to participate in the study for an additional 6 months, for a total of up to 12 study visits.